topic: Tuberculosis

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
From Nhlangano to the Future, MSF’s legacy in Shiselweni region: 5 key facts about MSF in Eswatini
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis
Between life and living: Patients with drug-resistant tuberculosis (DR-TB) share stories of strength, support and suffering
Emerging resistance to new anti-tuberculosis drug bedaquiline warrants urgent action: Médecins Sans Frontières (MSF) Policy Brief